265 related articles for article (PubMed ID: 20625123)
21. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with response to methylphenidate in advanced cancer patients.
Yennurajalingam S; Palmer JL; Chacko R; Bruera E
Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
[TBL] [Abstract][Full Text] [Related]
23. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatments for fatigue associated with palliative care.
Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
[TBL] [Abstract][Full Text] [Related]
25. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
26. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Lower EE; Harman S; Baughman RP
Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
29. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
[TBL] [Abstract][Full Text] [Related]
30. Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
Weisler RH; Pandina GJ; Daly EJ; Cooper K; Gassmann-Mayer C;
CNS Drugs; 2012 May; 26(5):421-34. PubMed ID: 22519922
[TBL] [Abstract][Full Text] [Related]
31. The use of methylphenidate to relieve fatigue.
Rojí R; Centeno C
Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.
Sugawara Y; Akechi T; Shima Y; Okuyama T; Akizuki N; Nakano T; Uchitomi Y
Palliat Med; 2002 May; 16(3):261-3. PubMed ID: 12047006
[No Abstract] [Full Text] [Related]
33. Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.
Sullivan DR; Mongoue-Tchokote S; Mori M; Goy E; Ganzini L
Psychooncology; 2017 Nov; 26(11):1763-1769. PubMed ID: 27429350
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.
Barton DL; Soori GS; Bauer BA; Sloan JA; Johnson PA; Figueras C; Duane S; Mattar B; Liu H; Atherton PJ; Christensen B; Loprinzi CL
Support Care Cancer; 2010 Feb; 18(2):179-87. PubMed ID: 19415341
[TBL] [Abstract][Full Text] [Related]
35. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
[TBL] [Abstract][Full Text] [Related]
37. A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Huang YS; Yeh CB; Chen CH; Shang CY; Gau SS
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):164-178. PubMed ID: 33395356
[No Abstract] [Full Text] [Related]
38. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
[TBL] [Abstract][Full Text] [Related]
39. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
